title: Nanobiotechnology for the Therapeutic Targeting of Cancer Cells in Blood.
abstract: During metastasis, circulating tumor cells migrate away from a primary tumorviathe blood circulation to form secondary tumors in distant organs. Mounting evidence from clinical observations indicates that the number of circulating tumor cells (CTCs) in the blood correlates with the progression of solid tumors before and during chemotherapy. Beyond the well-established role of CTCs as a fluid biopsy, however, the field of targeting CTCs for the prevention or reduction of metastases has just emerged. Conventional cancer therapeutics have a relatively short circulation time in the blood which may render the killing of CTCs inefficient due to reduced exposure of CTCs to drugs. Nevertheless, over the past few decades, the development of nanoparticles and nanoformulations to improve the half-life and release profile of drugs in circulation has rejuvenated certain traditional medicines in the emerging field of CTC neutralization. This review focuses on how the principles of nanomedicine may be applied to target CTCs. Moreover, inspired by the interactions between CTCs and host cells in the blood circulation, novel biomimetic approaches for targeted drug delivery are presented.
authors: Department of Biomedical Engineering, Cornell University, 205 Weill Hall, Ithaca, NY 14853 USA.
authors: Jiahe
authors: J
authors: Li
authors: Department of Biomedical Engineering, Cornell University, 205 Weill Hall, Ithaca, NY 14853 USA.
authors: Charles C
authors: CC
authors: Sharkey
authors: Department of Biomedical Engineering, Cornell University, 205 Weill Hall, Ithaca, NY 14853 USA.
authors: Dantong
authors: D
authors: Huang
authors: Department of Biomedical Engineering, Cornell University, 205 Weill Hall, Ithaca, NY 14853 USA.
authors: Michael R
authors: MR
authors: King
keywords: Circulating tumor cells; Metastasis; Nanomedicine